Concepedia

Safe and Effective Use of the Once Weekly Dulaglutide Single-Dose Pen in Injection-Naïve Patients With Type 2 Diabetes

Glenn Matfin, Kate Van Brunt, Alan G. Zimmermann, Rebecca Threlkeld, Debra A. Ignaut

Journal of Diabetes Science and Technology · 2015 · 49 citations · 16 references

DOIFull text

Open access

Abstract

The dulaglutide single-dose pen was found to be a safe and effective device for use by patients with T2D who were injection-naïve. A positive injection experience is an important factor for patients and providers when initiating injectable therapy.

References

16

Resistance to Insulin Therapy Among Patients and Providers

Mark Peyrot, Richard R. Rubin, Torsten Lauritzen et al. · Diabetes Care · 2005 · 773 citations · Full text

Correlates of Insulin Injection Omission

Mark Peyrot, Richard R. Rubin, Davida Kruger et al. · Diabetes Care · 2010 · 393 citations · Full text

Quality of Life, Treatment Satisfaction, and Treatment Preference Associated With Use of a Pen Device Delivering a Premixed 70/30 Insulin Aspart Suspension (Aspart Protamine Suspension/Soluble Aspart) Versus Alternative Treatment Strategies

Richard R. Rubin, Mark Peyrot · Diabetes Care · 2004 · 119 citations · Full text

, , +15

Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single‐centre, randomized controlled trial

Tim Heise, Leszek Nosek, Sibylle Dellweg et al. · Diabetes Obesity and Metabolism · 2014 · 105 citations

Patient satisfaction with diabetes care

Åsa Hörnsten, Berit Lundman, Eva Kihl Selstam et al. · Journal of Advanced Nursing · 2005 · 88 citations